Showing results (491-500 of 509) with videos related to

Sort By:
Pageof 51
British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
International Journal of Cancer|May 6, 2015
TERT gene harbors multiple variants associated with pancreatic cancer susceptibilityDaniele Campa, Cosmeri Rizzato, Rachael Stolzenberg-Solomon, et al.
Frontiers in Oncology|December 20, 2021
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer RiskYe Lu, Manuel Gentiluomo, Angelica Macauda, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2021
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer RiskGiulia Peduzzi, Manuel Gentiluomo, Francesca Tavano, et al.
Human Genomics|February 3, 2024
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma riskPelin Ünal, Ye Lu, Bas Bueno-de-Mesquita, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Science Translational Medicine|July 19, 2019
A multimodality test to guide the management of patients with a pancreatic cystSimeon Springer, David L Masica, Marco Dal Molin, et al.
Mutagenesis|April 12, 2024
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinomaMatteo Giaccherini, Mariaconcetta Rende, Manuel Gentiluomo, et al.
Biological Research|August 13, 2023
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in EurasiansMargherita Piccardi, Manuel Gentiluomo, Stefania Bertoncini, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Pageof 51